Covetrus Inc. (Nasdaq: CVET), the Portland-based provider of animal-health products and services, on Tuesday reported a fourth-quarter net loss of $37 million and announced Benjamin Wolin as its new president and CEO.
In late morning trading Wednesday, shares were up 14%, trading at $12.69. That gives the stock an equity value of around $14.1 billion.
Wolin will transition from the acting role he has held since October when he replaced CEO Benjamin Shaw. Read more
The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...
Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...
The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...